-
Jun 16, 2015, 15:00 PM
by
Michael Croft
Bio-IT World News Brief | Tute Genomics today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including Intermountain Healthcare, Healthbox, and China-based Tencent.
Full story
-
Jun 16, 2015, 08:50 AM
by
Michael Croft
Bio-IT World News Brief | Nature Methods has published a paper by researchers at the University of Birmingham and University of Toronto, demonstrating a complete de novo assembly of an E. coli genome using only data from an Oxford Nanopore MinION Sequencer.
Full story
-
Jun 16, 2015, 00:00 AM
by
Michael Croft
Xconomy | Trunnell leaves the Broad to serve as
the chief information officer as the biomedical institution moves
into an era of deep genomic sequencing.
Full story
-
Jun 16, 2015, 00:00 AM
by
Michael Croft
mobihealthnews | PatientsLikeMe has announced a
research partnership with the FDA: The agency will assess the
platform's feasibility as a way to generate adverse event reports,
which the FDA uses to regulate drugs after their release into the
market.
Full story
-
Jun 11, 2015, 00:00 AM
by
Michael Croft
SAN DIEGO, CA, UNITED STATES - Jun 11, 2015 - Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia
Full story
-
Jun 10, 2015, 13:30 PM
by
Michael Croft
Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.
Full story
-
Jun 10, 2015, 10:00 AM
by
Michael Croft
Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.
Full story
-
Jun 9, 2015, 00:00 AM
by
Michael Croft
BOSTON, MA, UNITED STATES - Jun 9, 2015 - London, UK
& Boston, USA. June 9th 2015: Digital Science
announced today the appointment of Daniel Hook, currently Director
of Research Metrics at Digital Science, as its new Managing
Director
Full story
-
Jun 8, 2015, 17:00 PM
by
Michael Croft
Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.
Full story
-
Jun 8, 2015, 16:00 PM
by
Michael Croft
Bio-IT World | David Mittelman and his colleagues at N of Everyone today
launch a Kickstarter campaign to fund Reader, a mobile and social reading
platform to promote conversation and collaboration within science.
Full story
-
Jun 8, 2015, 00:00 AM
by
Michael Croft
NEW YORK, NY - Jun 8, 2015 - BOC Sciences-recently a new synthetic molecule was introduced by an authoritative research center in America
Full story
-
Jun 5, 2015, 13:50 PM
by
Michael Croft
Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
Full story
-
Jun 5, 2015, 00:00 AM
by
Michael Croft
CHAPEL HILL, NC - Jun 5, 2015 - For Immediate
Release Rho Chairman and Co-Founder Ronald W.
Helms Inducted as a FellowOf the Society for
Clinical Trials Chapel Hill, NC ̶
June 4, 2015 ̶ Rho, a contract research
organization (CRO) focused on bringing new products to market
through a full range of product development services, recently
announced that its Chairman and Co-founder Ronald W
Full story
-
Jun 5, 2015, 00:00 AM
by
Michael Croft
OXFORD, UNITED KINGDOM - Jun 5, 2015 - Motion capture technology specialist Vicon has announced growing momentum in the life sciences sector with several recent customer wins
Full story
-
Jun 4, 2015, 00:00 AM
by
Michael Croft
Xconomy | The immuno-oncology field is moving fast
these days, but the tough-to-treat blood cancer multiple myeloma
has not been one of its early targets.
Full story
-
Jun 4, 2015, 00:00 AM
by
Michael Croft
ALBANY, UNITED STATES - Jun 4, 2015 - Market Research Reports
Search Engine (MRRSE) has announced the addition of the
' Frontier Pharma: Parkinsons Disease - Identifying
and Commercializing First-in-Class Innovation' report by
Market Research Reports Search Engine to its rapidly growing market
research report database
Full story
-
Jun 4, 2015, 00:00 AM
by
Michael Croft
Nature News & Comment | Moderna Therapeutics
has big ambitions and a bankroll to match. How a fledgling start-up
became one of the most highly valued private drug firms ever.
Full story
-
Jun 3, 2015, 13:00 PM
by
Michael Croft
Bio-IT World News Brief | Genomics England today announced four finalist companies and one alternate that will begin working on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project. Congenica and Omicia will work in rare diseases, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project. Lockheed Martin in partnership with Cypher Genomics is the alternate.
Full story
-
Jun 3, 2015, 00:00 AM
by
Michael Croft
PHILADELPHIA, PA, UNITED STATES - Jun 3, 2015 - The Intellectual Property and Science business of Thomson Reuters, the worlds leading provider of intelligent information for businesses and professionals, recently honored Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year
Full story
-
Jun 2, 2015, 15:00 PM
by
Michael Croft
Bio-IT World | BaseHealth, an Illumina-associated company using genomic data to provide patients with personalized health recommendations, is shifting to a more behind-the-scenes model, releasing an open API to integrate its own analysis engine into third-party apps and health platforms.
Full story